LAS VEGAS, NV, July 12, 2017 --
Praxsyn Corporation (OTCQB: PXYN) is pleased to announce that its wholly owned subsidiary pharmacy, Nevada Health Rx, Inc. (“NHRX”), located in Las Vegas, Nevada, is taking prescriptions on lien with home delivery for personal injury patients.
NHRX accepts and will provide prescriptions for people injured in a variety of ways with clear liability, including auto accidents, slip and fall injuries and dog bite cases which are just to name a few types of injuries in which NHRX will provide medications to patients on lien. Our home delivery and competitive pricing provides a valued service to the patient while they recover from their traumatic and often debilitating experience.
Praxsyn’s Chief Executive Officer, Greg Sundem, commented, “personal injury claims can be a very secure and lucrative market for our pharmacy division, and we have established internal systems to manage the collection process to ensure a profitable business line. I am pleased to be expanding our business in Nevada with additional licensing in other strategic markets”.
About Praxsyn Corporation
Headquartered in Las Vegas, Nevada, Praxsyn Corporation through its wholly owned subsidiaries Mesa Pharmacy and Nevada Health Rx, work to realize the vision of medical professionals to improve the lives of their patients. Additional company information can be found at www.praxsyn.com.
Forward-Looking Statements
Certain statements made in this press release are forward-looking in nature (within the meaning of the Private Securities Litigation Reform Act of 1995) including but not limited to statements in this press release regarding prescriptions on lien for personal injury patients, and thus accordingly, are subject to risks and uncertainties. The actual results may differ materially from those described or contemplated and consequently, you should not rely on these forward-looking statements as predictions of future events. Certain of these risks and uncertainties are discussed in the reports as have been filed with the Securities and Exchange Commission.
###
Media/Investor Contact: [email protected] 949-777-6112 ext. 101


KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
First Western Ship Transits Strait of Hormuz Since Iran War Began
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports 



